DOW JONES25,409.36-357.28 -1.39%
S&P 5002,954.22-24.54 -0.82%
NASDAQ8,567.37+0.89 0.01%

Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $278

Credit Suisse maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $275 to $278.

Benzinga · 01/31/2020 13:59

Credit Suisse maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $275 to $278.